|
TMEM170A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47499999999068E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46359999997348E-06 |
| Normal-vs-Stage2 |
1.975750E-01 |
| Normal-vs-Stage3 |
7.208200E-02 |
| Normal-vs-Stage4 |
3.375900E-02 |
| Stage1-vs-Stage2 |
3.242000E-01 |
| Stage1-vs-Stage3 |
3.529600E-01 |
| Stage1-vs-Stage4 |
8.098200E-01 |
| Stage2-vs-Stage3 |
8.988800E-01 |
| Stage2-vs-Stage4 |
4.812400E-01 |
| Stage3-vs-Stage4 |
4.984200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.32369999999938E-05 |
| Normal-vs-AfricanAmerican |
1.141430E-03 |
| Normal-vs-Asian |
7.763800E-01 |
| Caucasian-vs-AfricanAmerican |
7.776000E-01 |
| Caucasian-vs-Asian |
4.479800E-01 |
| AfricanAmerican-vs-Asian |
4.013800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06200000002688E-06 |
| Normal-vs-Female |
3.274200E-02 |
| Male-vs-Female |
1.357040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.032710E-04 |
| Normal-vs-Extreme_Weight |
2.57579999551893E-08 |
| Normal-vs-Obese |
7.251900E-02 |
| Normal-vs-Extreme_Obese |
5.123600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.441400E-01 |
| Normal_Weight-vs-Obese |
6.528100E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.700830E-01 |
| Extreme_Weight-vs-Obese |
1.286480E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.088100E-02 |
| Obese-vs-Extreme_Obese |
8.381000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.698500E-03 |
| Normal-vs-Age(41-60Yrs) |
9.862400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.88405000000058E-05 |
| Normal-vs-Age(81-100Yrs) |
5.18960000528423E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.001600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.104400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.053590E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.866300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.595300E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.223900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.630530E-04 |
| Normal-VS-Type2 PRCC |
1.607140E-04 |
| Normal-VS-KIRP CIMP |
1.382100E-02 |
| Normal-VS-Unclassified PRCC |
2.060400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.203800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.153600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.869000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.498000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.001200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.123000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.805200E-04 |
| Normal-vs-N1 |
3.031900E-02 |
| Normal-vs-N2 |
3.3700999999553E-06 |
| N0-vs-N1 |
3.932000E-01 |
| N0-vs-N2 |
1.634750E-01 |
| N1-vs-N2 |
2.897600E-02 |
|
|
